TFAP2B
TFAP2B (transcription factor AP-2 beta, also known as AP2-B or AP-2beta) is a sequence-specific DNA-binding transcription factor of the AP-2 family. It acts as both an activator and a repressor of selected genes, and it contributes to facial, limb and renal development. Browse Assay Genie's current range of TFAP2B research reagents below, or read on for the biology behind the target.
TFAP2B is a sequence-specific DNA-binding transcription factor that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. Like other AP-2 factors, it binds the consensus sequence 5'-GCCNNNGGC-3' and activates genes involved in a wide spectrum of biological functions, including development of the eye, face, body wall, limb and neural tube. It also suppresses a number of genes, among them MCAM/MUC18, C/EBP alpha and MYC. Within this family, TFAP2B appears to be required for normal face and limb development and for proper terminal differentiation and function of renal tubular epithelia.
The TFAP2B gene encodes a member of the AP-2 family of transcription factors, and the TFAP2B protein is found in the nucleus. AP-2 family members form homo- or hetero-dimers with one another and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Individual family members differ in their expression patterns and in their binding affinity for different promoters, which is one reason the paralogues TFAP2A and TFAP2C are often studied alongside TFAP2B. The mouse ortholog is Tfap2b, which makes the gene accessible to developmental studies in that species.
The gene has previously been described as transcription factor AP-2 beta (activating enhancer-binding protein 2 beta), a name that reflects its original characterisation as an enhancer-binding factor. Mutations in TFAP2B cause autosomal dominant Char syndrome, which suggests that the gene functions in the differentiation of neural crest cell derivatives. This link between a single transcription factor and a defined developmental disorder makes TFAP2B a useful subject for work on gene regulation, craniofacial and limb patterning, and kidney epithelial biology.
TFAP2B activates genes needed for eye, face, body wall, limb and neural tube development, making it a focus for studies of embryonic patterning.
Mutations in TFAP2B cause Char syndrome, pointing to a role in the differentiation of neural crest cell derivatives.
TFAP2B appears to be required for proper terminal differentiation and function of renal tubular epithelia.
TFAP2B binds the 5'-GCCNNNGGC-3' consensus and both activates and represses targets, including suppression of MYC and C/EBP alpha.
TFAP2B is a nuclear transcription factor that binds the consensus sequence 5'-GCCNNNGGC-3' and regulates selected genes as an activator or repressor. It supports development of the face and limbs and the differentiation and function of renal tubular epithelia, and it suppresses genes such as MYC and C/EBP alpha.
TFAP2B stands for transcription factor AP-2 beta. Aliases include AP2-B and AP-2beta, and earlier names describe it as activating enhancer-binding protein 2 beta. The UniProt entry calls it Transcription factor AP-2-beta, and it belongs to the AP-2 family of transcription factors.
Mutations in TFAP2B result in autosomal dominant Char syndrome, suggesting a role in neural crest derivative differentiation. The mouse ortholog is Tfap2b. Researchers working across species should check the datasheet of any product for its validated reactivity.
Other AP-2 family transcription factors and genes regulated by TFAP2B with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92481; product specifications from Assay Genie datasheets.